These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31619067)

  • 21. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
    Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy.
    Moroney LB; Helios J; Ward EC; Crombie J; Wockner LF; Burns CL; Spurgin AL; Blake C; Kenny L; Hughes BG
    Oral Oncol; 2017 Jan; 64():1-8. PubMed ID: 28024718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
    Vacha P; Marx M; Engel A; Richter E; Feyerabend T
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an oral assessment tool to evaluate appetite in patients with head and neck cancer receiving radiotherapy.
    Ogama N; Ogama N
    Eur J Oncol Nurs; 2013 Aug; 17(4):474-81. PubMed ID: 23164924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy.
    Sapir E; Tao Y; Feng F; Samuels S; El Naqa I; Murdoch-Kinch CA; Feng M; Schipper M; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):354-361. PubMed ID: 27473816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma].
    Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial.
    Bonner JA; Giralt J; Harari PM; Baselga J; Spencer S; Bell D; Raben D; Liu J; Schulten J; Ang KK; Rosenthal DI
    Eur J Cancer; 2016 Sep; 64():1-11. PubMed ID: 27323346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral secondary effects of radiotherapy and chemotherapy in cancer of the cervicofacial region].
    Bascones-Martínez A; Muñoz-Corcuera M; Gómez-Font R
    Med Clin (Barc); 2013 Jul; 141(2):77-81. PubMed ID: 23664688
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of low-level laser therapy for oral mucositis prevention in patients undergoing chemoradiotherapy for the treatment of head and neck cancer: A systematic review and meta-analysis.
    de Lima VHS; de Oliveira-Neto OB; da Hora Sales PH; da Silva Torres T; de Lima FJC
    Oral Oncol; 2020 Mar; 102():104524. PubMed ID: 32062592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients.
    Gu F; Farrugia MK; Duncan WD; Feng Y; Hutson AD; Schlecht NF; Repasky EA; Antoch MP; Miller A; Platek A; Platek ME; Iovoli AJ; Singh AK
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):949-955. PubMed ID: 32098893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helical intensity-modulated radiotherapy with concurrent chemotherapy for oropharyngeal squamous cell carcinoma: A prospective investigation of acute swallowing and toxicity patterns.
    Moroney LB; Helios J; Ward EC; Crombie J; Pelecanos A; Burns CL; Spurgin AL; Blake C; Kenny L; Chua B; Hughes BGM
    Head Neck; 2018 Sep; 40(9):1955-1966. PubMed ID: 29756244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
    Adeberg S; Akbaba S; Lang K; Held T; Verma V; Nikoghosyan A; Bernhardt D; Münter M; Freier K; Plinkert P; Hauswald H; Herfarth K; Rieken S; Debus J; Jensen AD
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):167-173. PubMed ID: 31586664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus.
    Morais-Faria K; Palmier NR; de Lima Correia J; de Castro Júnior G; Dias RB; da Graça Pinto H; Lopes MA; Ribeiro ACP; Brandão TB; Santos-Silva AR
    Support Care Cancer; 2020 Sep; 28(9):4345-4352. PubMed ID: 31912359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].
    Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gérard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Bénézery K; Hérault J; Bourhis J; Thariat J;
    Cancer Radiother; 2019 Sep; 23(5):439-448. PubMed ID: 31358445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrical stimulation of post-irradiated head and neck squamous cell carcinoma to improve xerostomia.
    Pattani KM; McDuffie CM; Morgan M; Armstrong C; Nathan CO
    J La State Med Soc; 2010; 162(1):21-5. PubMed ID: 20336953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol.
    Morais MO; Martins AFL; de Jesus APG; de Sousa Neto SS; da Costa AWF; Pereira CH; Oton-Leite AF; de Freitas NMA; Leles CR; Mendonça EF
    Support Care Cancer; 2020 Sep; 28(9):4263-4273. PubMed ID: 31900618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oral complications in patients with head and neck cancer after radio-chemotherapy. Mucositis and xerostomia].
    Di Liberto C; Caroprese M; Pizzo G; Compilato D; Fulfaro F; Rinaldi T; Lo Muzio L; Campisi G
    Recenti Prog Med; 2007 May; 98(5):302-14. PubMed ID: 17580521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gustatory disturbances occur in patients with head and neck cancer who undergo radiotherapy not directed to the oral cavity.
    Barbosa da Silva JL; Doty RL; Miyazaki JVMK; Borges R; Pinna FR; Voegels RL; Fornazieri MA
    Oral Oncol; 2019 Aug; 95():115-119. PubMed ID: 31345378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.
    Bhide SA; Gulliford S; Schick U; Miah A; Zaidi S; Newbold K; Nutting CM; Harrington KJ
    Radiother Oncol; 2012 Apr; 103(1):88-91. PubMed ID: 22280809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.
    Baudelet M; Van den Steen L; Tomassen P; Bonte K; Deron P; Huvenne W; Rottey S; De Neve W; Sundahl N; Van Nuffelen G; Duprez F
    Head Neck; 2019 Oct; 41(10):3594-3603. PubMed ID: 31329343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.